Ioannis Tsamesidis

Dr. Ioannis Tsamesidis

UMR 152 Pharma-Dev, Université de Toulouse, IRD, UPS, 31000 Toulouse, France
+1
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
GPGeorgia K. Pouroutzidou
Georgia K. Pouroutzidou
Liliana LiveraniLiliana Liverani
Liliana Liverani
ATAnna Theocharidou
Anna Theocharidou
Ioannis TsamesidisIoannis Tsamesidis
Ioannis Tsamesidis
Maria LazaridouMaria Lazaridou
Maria Lazaridou
EKEleana Kontonasaki
Eleana Kontonasaki
Mesoporous silica-based nanoparticles (MSNs) are considered promising drug carriers because of their ordered pore structure, which permits high drug loading and release capacity. The dissolution of Si and Ca from MSNs can trigger osteogenic differentiation of stem cells towards extracellular matrix calcification, while Mg and Sr constitute key elements of bone biology and metabolism. The aim of this study was the synthesis and characterization of sol–gel-derived MSNs co-doped with Ca, Mg and Sr. Their physico-chemical properties were investigated by X-ray diffraction (XRD), scanning electron microscopy with energy dispersive X-ray analysis (SEM/EDX), transmission electron microscopy (TEM), Fourier transform infrared spectroscopy (FTIR), X-ray fluorescence spectroscopy (XRF), Brunauer Emmett Teller and Brunauer Joyner Halenda (BET/BJH), dynamic light scattering (DLS) and ζ-potential measurements. Moxifloxacin loading and release profiles were assessed with high performance liquid chromatography (HPLC) cell viability on human periodontal ligament fibroblasts and their hemolytic activity in contact with human red blood cells (RBCs) at various concentrations were also investigated. Doped MSNs generally retained their textural characteristics, while different compositions affected particle size, hemolytic activity and moxifloxacin loading/release profiles. All co-doped MSNs revealed the formation of hydroxycarbonate apatite on their surface after immersion in simulated body fluid (SBF) and promoted mitochondrial activity and cell proliferation.

1 February 2022 in Free Radical Biology and Medicine
Verified
Journal Article
Open access
CEChinedu Ogbonnia Egwu
Chinedu Ogbonnia Egwu
PPPierre PERIO
Pierre PERIO
JAJean-Michel Augereau
Jean-Michel Augereau
Ioannis TsamesidisIoannis Tsamesidis
Ioannis Tsamesidis
FBFrançoise Benoit-Vical
Françoise Benoit-Vical
KRKarine Reybier
Karine Reybier
Malaria remains a major public health disease due to its high yearly mortality and morbidity. Resistance to the gold standard drug, artemisinin, is worrisome and needs better understanding in order to be overcome. In this work, we sought to study whether redox processes are involved in artemisinin resistance. As artemisinin is known to act among others via production of reactive species, we first compared the production of reactive oxygen species and concomitant protein oxidation in artemisinin-sensitive and artemisinin-resistant parasites when treated with artemisinin. The results undoubtedly demonstrated, using different original methods, that the level of ROS, including superoxide production, and oxidized protein were lower in the resistant strain. Interestingly, the major in-between strain difference was reported at the earlier ring stages, which are the forms able to enter in a quiescence state according to the ART resistance phenomenon. Moreover, we demonstrated a better homeostasis regulation in relation with higher expression of antioxidants in the artemisinin-resistant parasites than their sensitive counterparts after artemisinin exposure, notably, superoxide dismutase and the glutathione (GSH) system. These findings enrich the body of knowledges about the multifaceted mechanism of artemisinin resistance and will help in the design and development of newer antimalarials strategies active against resistant parasites.

1 September 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EAElisabetta Avitabile
Elisabetta Avitabile
NSNina Senes
Nina Senes
CDCristina D’aVino
Cristina D’aVino
Ioannis TsamesidisIoannis Tsamesidis
Ioannis Tsamesidis
APAlessandra Pinna
Alessandra Pinna
APAntonella Pantaleo
Antonella Pantaleo
Malaria represents one of the most common infectious diseases which becoming an impellent public health problem worldwide. Antimalarial classical medications include quinine-based drugs, like chloroquine, and artesunate, a derivative of artemisinin, a molecule found in the plant Artemisia annua. Such therapeutics are very effective but show heavy side effects like drug resistance. In this study, “green” silver nanoparticles (AgNPs) have been prepared from two Artemisia species (A. abrotanum and A. arborescens), traditionally used in folk medicine as a remedy for different conditions, and their potential antimalarial efficacy have been assessed. AgNPs have been characterized by UV-Vis, dynamic light scattering and zeta potential, FTIR, XRD, TEM and EDX. The structural characterization has demonstrated the spheroidal shape of nanoparticles and dimensions under 50 nm, useful for biomedical studies. Zeta potential analysis have shown the stability and dispersion of green AgNPs in aqueous medium without aggregation. AgNPs hemocompatibility and antimalarial activity have been studied in Plasmodium falciparum cultures in in vitro experiments. The antiplasmodial effect has been assessed using increasing doses of AgNPs (0.6 to 7.5 μg/mL) on parasitized red blood cells (pRBCs). Obtained data showed that the hemocompatibility of AgNPs is related to their synthetic route and depends on the administered dose. A. abrotanum-AgNPs (1) have shown the lowest percentage of hemolytic activity on pRBCs, underlining their hemocompatibility. These results are in accordance with the lower levels of parasitemia observed after A. abrotanum-AgNPs (1) treatment respect to A. arborescens-AgNPs (2), and AgNPs (3) derived from a classical chemical synthesis. Moreover, after 24 and 48 hours of A. abrotanum-AgNPs (1) treatment, the parasite growth was locked in the ring stage, evidencing the effect of these nanoparticles to hinder the maturation of P. falciparum. The anti-malarial activity of A. abrotanum-AgNPs (1) on pRBCs was demonstrated to be higher than that of A. arborescens-AgNPs (2).

23 October 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ICIason Chatzimentor
Iason Chatzimentor
Ioannis TsamesidisIoannis Tsamesidis
Ioannis Tsamesidis
MIMaria Eleni Ioannou
Maria Eleni Ioannou
GPGeorgia K. Pouroutzidou
Georgia K. Pouroutzidou
ABAnastasia BEKETOVA
Anastasia BEKETOVA
EKEleana Kontonasaki
Eleana Kontonasaki
(1) Background: An element that has gained much attention in industrial and biomedical fields is Cerium (Ce). CeO2 nanoparticles have been proven to be promising regarding their different biomedical applications for the control of infection and inflammation. The aim of the present study was to investigate the biological properties and antimicrobial behavior of cerium oxide (CeO2) nanoparticles (NPs). (2) Methods: The investigation of the NPs’ biocompatibility with human periodontal ligament cells (hPDLCs) was evaluated via the MTT assay. Measurement of alkaline phosphatase (ALP) levels and alizarine red staining (ARS) were used as markers in the investigation of CeO2 NPs’ capacity to induce the osteogenic differentiation of hPDLCs. Induced inflammatory stress conditions were applied to hPDLCs with H2O2 to estimate the influence of CeO2 NPs on the viability of cells under these conditions, as well as to reveal any ROS scavenging properties. Total antioxidant capacity (TAC) of cell lysates with NPs was also investigated. Finally, the macro broth dilution method was the method of choice for checking the antibacterial capacity of CeO2 against the anaerobic pathogens Porphyromonas gingivalis and Prevotella intermedia. (3) Results: Cell viability assay indicated that hPDLCs increase their proliferation rate in a time-dependent manner in the presence of CeO2 NPs. ALP and ARS measurements showed that CeO2 NPs can promote the osteogenic differentiation of hPDLCs. In addition, the MTT assay and ROS determination demonstrated some interesting results concerning the viability of cells under oxidative stress conditions and, respectively, the capability of NPs to decrease free radical levels over the course of time. Antimicrobial toxicity was observed mainly against P. gingivalis. (4) Conclusions: CeO2 NPs could provide an excellent choice for use in clinical practices as they could prohibit bacterial proliferation and control inflammatory conditions.

1 May 2021 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
CEChinedu Ogbonnia Egwu
Chinedu Ogbonnia Egwu
Ioannis TsamesidisIoannis Tsamesidis
Ioannis Tsamesidis
PPPierre Pério
Pierre Pério
JAJean-Michel Augereau
Jean-Michel Augereau
FBFrançoise Benoit-Vical
Françoise Benoit-Vical
KRKarine Reybier
Karine Reybier

24 August 2017 in Blood
Verified
Journal Article
Open access
PDF file
APAntonella Pantaleo
Antonella Pantaleo
KKKristina R. Kesely
Kristina R. Kesely
MPMaria Carmina Pau
Maria Carmina Pau
Ioannis TsamesidisIoannis Tsamesidis
Ioannis Tsamesidis
ESEvelin Schwarzer
Evelin Schwarzer
FTFrancesco M. Turrini
Francesco M. Turrini
Key Points: Inhibitors of human Syk kinase suppress parasite egress. Syk inhibitors prevent the tyrosine phosphorylation of band 3 in P falciparum parasitized red blood cells, reducing the release of microparticles.